France Life Imaging convened its “Biomedical Imaging Advisory Board” on December 9, 2022. The Infrastructure has proposed to rename the initial Scientific Advisory board into the Biomedical Imaging Advisory Board, as part of the infrastructure renewal project to be submitted for evaluation by an international jury in 2019.
Indeed,the term ” Scientist” in the SAB of the initial project was the source of some confusion. The FLI coordinator cannot be held responsible for the scientific value of the work carried out on these platforms. Each platform is backed by at least one research team, evaluated in the French system by the Hcéres, the universities and the research organizations, which oversee the research units. The term “Conseil Scientifique” is therefore inappropriate for assessing the infrastructure, and we have preferred the term “Biomedical Imaging Advisory Board” (BIAB). In this sense, the scientific results (publications and patents) obtained on the FLI platforms are certainly an element, but the board’s assessment focuses more on the infrastructure’s policy than on these results.
This board includes the 4 recognized experts in the field of FLI’s activities:
- Jacques BITTOUN, former President of Université Paris-Sud
- Claire COROT, TRUFFLE Capital, former Director of Guerbet’s Research Department
- Jolanta KUNIKOWSKA, Medical Department, University of Warsaw, President of the European Association of Nuclear Medicine (EANM)
- Oliver SPECK, Institute of Physics, Faculty of Science, Otto von Guericke University, Magdeburg.
Attached is the report submitted to BIAB for the event: 2022-11 FLI-Activity-Report
The open discussions and numerous exchanges made for a very constructive day,
